Search research articles
Contact Us
Filters
Showing results (601-610 of 717) with videos related to
Page
of 72
Sort By:
Blood Cancer Journal
|
June 17, 2021
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
Sabela Bobillo, Erel Joffe, David Sermer, et al.
Advances in Radiation Oncology
|
September 12, 2018
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities
Canhua Xiao, Jennifer Moughan, Benjamin Movsas, et al.
European Urology
|
June 19, 2024
Corrigendum to "Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial" [Eur. Eurol. 84(2) (2023) 156-163]
Oliver Sartor, Theodore G Karrison, Howard M Sandler, et al.
Molecular Psychiatry
|
October 20, 2019
Clinical, cortical thickness and neural activity predictors of future affective lability in youth at risk for bipolar disorder: initial discovery and independent sample replication
Michele A Bertocci, Lindsay Hanford, Anna Manelis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2021
Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring
Caitlin M Stewart, Laure Michaud, Karissa Whiting, et al.
Blood Advances
|
August 19, 2025
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell Lymphoma
Swaminathan P Iyer, Neha Mehta-Shah, Ranjana H Advani, et al.
Blood
|
December 19, 2013
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma
Oreofe Odejide, Oliver Weigert, Andrew A Lane, et al.
European Urology
|
January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial
Loren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 2, 2023
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Himanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 29, 2016
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer
Skyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, et al.
Page
of 72
Search research articles
Search
Showing results (601-610 of 717) with videos related to
Sort By:
Page
of 72
Blood Cancer Journal
|
June 17, 2021
Prophylaxis with intrathecal or high-dose methotrexate in diffuse large B-cell lymphoma and high risk of CNS relapse
Sabela Bobillo, Erel Joffe, David Sermer, et al.
Advances in Radiation Oncology
|
September 12, 2018
Risk factors for late bowel and bladder toxicities in NRG Oncology prostate cancer trials of high-risk patients: A meta-analysis of physician-rated toxicities
Canhua Xiao, Jennifer Moughan, Benjamin Movsas, et al.
European Urology
|
June 19, 2024
Corrigendum to "Androgen Deprivation and Radiotherapy with or Without Docetaxel for Localized High-risk Prostat Cancer: Long-term Follow-up from the Randomized NRG Oncology RTOG 0521 Trial" [Eur. Eurol. 84(2) (2023) 156-163]
Oliver Sartor, Theodore G Karrison, Howard M Sandler, et al.
Molecular Psychiatry
|
October 20, 2019
Clinical, cortical thickness and neural activity predictors of future affective lability in youth at risk for bipolar disorder: initial discovery and independent sample replication
Michele A Bertocci, Lindsay Hanford, Anna Manelis, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 7, 2021
Phase I/Ib Study of the Efficacy and Safety of Buparlisib and Ibrutinib Therapy in MCL, FL, and DLBCL with Serial Cell-Free DNA Monitoring
Caitlin M Stewart, Laure Michaud, Karissa Whiting, et al.
Blood Advances
|
August 19, 2025
Association of PET4 Response With Outcomes of BV-CHP vs CHOP in the ECHELON-2 Trial in CD30+ Peripheral T-cell Lymphoma
Swaminathan P Iyer, Neha Mehta-Shah, Ranjana H Advani, et al.
Blood
|
December 19, 2013
A targeted mutational landscape of angioimmunoblastic T-cell lymphoma
Oreofe Odejide, Oliver Weigert, Andrew A Lane, et al.
European Urology
|
January 29, 2023
Effects of Androgen Deprivation Therapy on Prostate Cancer Outcomes According to Competing Event Risk: Secondary Analysis of a Phase 3 Randomised Trial
Loren K Mell, Stephanie L Pugh, Christopher U Jones, et al.
International Journal of Radiation Oncology, Biology, Physics
|
January 2, 2023
Five-Year Patient-Reported Outcomes in NRG Oncology RTOG 0938, Evaluating Two Ultrahypofractionated Regimens for Prostate Cancer
Himanshu R Lukka, Snehal Deshmukh, Deborah W Bruner, et al.
Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology
|
November 29, 2016
Patient-reported quality of life after stereotactic body radiation therapy versus moderate hypofractionation for clinically localized prostate cancer
Skyler Bryce Johnson, Pamela R Soulos, Timothy D Shafman, et al.
Page
of 72